HCW Biologics Inc. (HCWB)
USD 0.41
(25.0%)
USD 0.41
(25.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.84 Million | 6.72 Million | - | 4.09 Million | - |
| Cost of Revenue | 3.41 Million | 4.13 Million | 543.59 Thousand | - | 421.81 Thousand |
| Gross Profit | -574.82 Thousand | 2.58 Million | -543.59 Thousand | 4.09 Million | -421.81 Thousand |
| Operating Expenses | 21.02 Million | 17.66 Million | 13.36 Million | 9.92 Million | 7.36 Million |
| Selling, General and Administrative Expenses | 13.08 Million | 8.32 Million | 4.97 Million | 2.43 Million | 1.8 Million |
| Research and Development Expenses | 7.67 Million | 9.33 Million | 8.17 Million | 7.25 Million | 5.39 Million |
| Other Expenses | 2.96 Million | 304.73 Thousand | 218.46 Thousand | 233.03 Thousand | 171.41 Thousand |
| Cost and Expenses | 28.55 Million | 21.8 Million | 13.36 Million | 9.92 Million | 7.36 Million |
| Operating Income | -25.71 Million | -15.07 Million | -13.36 Million | -5.82 Million | -7.36 Million |
| Interest Expense | 283.04 Thousand | 126.66 Thousand | - | - | - |
| Income Tax Expense | - | -178.07 Thousand | -505.36 Thousand | -22.32 Thousand | -72.35 Thousand |
| Earnings before Tax | -24.99 Million | -14.9 Million | -12.86 Million | -5.8 Million | -7.29 Million |
| Net Income | -24.99 Million | -14.72 Million | -12.35 Million | -5.77 Million | -7.22 Million |
| Earnings Per Share Basic | -0.70 | -0.41 | -0.35 | -0.16 | -0.20 |
| Earnings Per Share Diluted | -0.70 | -0.41 | -0.35 | -0.16 | -0.20 |
| Weighted Average Shares Outstanding | 35.92 Million | 35.82 Million | 35.76 Million | 36.7 Million | 36.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.92 Million | 35.82 Million | 35.76 Million | 36.7 Million | 36.7 Million |
| Gross Margin | -0.20 | 0.38 | - | 1.00 | - |
| EBIT Margin | -8.30 | -2.20 | - | -1.28 | - |
| Profit Margin | -8.80 | -2.19 | - | -1.41 | - |
| EBITDA | -23.57 Million | -14.18 Million | -12.82 Million | -5.25 Million | -6.94 Million |
| Earnings Before Tax Margin | -9.05 | -2.24 | - | -1.42 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 618.85 Thousand | 1.12 Million | 1.32 Million | 2.84 Million | 853.1 Thousand | 622.8 Thousand |
| Cost of Revenue | 568.37 Thousand | 755.46 Thousand | 1.34 Million | 3.41 Million | 678.32 Thousand | 502.4 Thousand |
| Gross Profit | 50.47 Thousand | 371.24 Thousand | -21.9 Thousand | -574.82 Thousand | 174.77 Thousand | 120.4 Thousand |
| Operating Expenses | 3.49 Million | 7.86 Million | 10.74 Million | 25.14 Million | 5.25 Million | 4.63 Million |
| Selling, General and Administrative Expenses | 1.52 Million | 5.91 Million | 8.6 Million | - | 3.52 Million | 2.94 Million |
| Research and Development Expenses | 1.96 Million | 1.94 Million | 2.13 Million | - | 1.66 Million | 1.61 Million |
| Other Expenses | -1.28 Million | 25.6 Thousand | 86.23 Thousand | 1 Million | 234.75 Thousand | 301.61 Thousand |
| Cost and Expenses | 4.06 Million | 8.62 Million | 12.09 Million | 28.55 Million | 5.93 Million | 5.13 Million |
| Operating Income | -3.44 Million | -7.49 Million | -10.76 Million | -25.71 Million | -5.07 Million | -4.51 Million |
| Interest Expense | 159.66 Thousand | - | -1423.00 | 283.04 Thousand | 95.51 Thousand | 95.51 Thousand |
| Income Tax Expense | -1.00 | -1.00 | -530.95 Thousand | -4.00 | 330.26 Thousand | 397.12 Thousand |
| Earnings before Tax | -15.28 Million | -7.46 Million | -10.68 Million | -24.99 Million | -4.93 Million | -4.3 Million |
| Net Income | -15.28 Million | -7.46 Million | -10.68 Million | -24.99 Million | -4.93 Million | -4.3 Million |
| Earnings Per Share Basic | -0.40 | -0.20 | -0.30 | - | -0.14 | -0.12 |
| Earnings Per Share Diluted | -0.40 | -0.20 | -0.30 | - | -0.14 | -0.12 |
| Weighted Average Shares Outstanding | 37.82 Million | 37.22 Million | 35.99 Million | 35.92 Million | 35.92 Million | 35.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.82 Million | 37.22 Million | 35.99 Million | 35.92 Million | 35.92 Million | 35.91 Million |
| Gross Margin | 0.08 | 0.33 | -0.02 | -0.20 | 0.20 | 0.19 |
| EBIT Margin | -5.35 | -6.43 | -7.93 | - | -5.35 | -6.30 |
| Profit Margin | -24.69 | -6.63 | -8.07 | -8.80 | -5.79 | -6.91 |
| EBITDA | -3.31 Million | -7.25 Million | -10.49 Million | - | -4.56 Million | -3.92 Million |
| Earnings Before Tax Margin | -5.56 | -6.65 | -8.13 | -9.05 | -5.95 | -7.24 |
LAL
DAL
2540
0340
CMD
ING